Etiopathogenesis, prediction, and prevention of preeclampsia

References

• Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatology 2009;33(3):130–137.
   PubMed Web of Science ®Google Scholar
• Bellamy L, Casas JP, Hingorani AD, Williams DL. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007;335(7627):974.
   PubMed Web of Science ®Google Scholar
• Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J 2008;156(5):918–930.
   PubMed Web of Science ®Google Scholar
• Mongraw-Chaffin ML, Cirillo PM, Cohn BA. Preeclampsia and cardiovascular disease death: prospective evidence from the child health and development studies cohort. Hypertension 2010;56(1):166–171.
   PubMed Web of Science ®Google Scholar
• Redman CW. Current topic: pre-eclampsia and the placenta. Placenta 1991;12(4):301–308.
   PubMed Web of Science ®Google Scholar
• Aplin JD. Implantation, trophoblast differentiation and haemochorial placentation: mechanistic evidence in vivo and in vitro. J Cell Sci 99(4);681–692.
   Google Scholar
• Rodesch F, Simon P, Donner C, Jauniaux E. Oxygen measurements in endometrial and trophoblastic tissues during early prengnancy. Obstetrics Gynecology 1992;80:283–285.
   PubMed Web of Science ®Google Scholar
• Genbacev O, Zhou Y, Ludlow JW, Fisher SJ. Regulation of human placental development by oxygen tension. Science 1997;277(5332):1669–1672.
   PubMed Web of Science ®Google Scholar
• King A, Hiby SE, Gardner L, Joseph S, Bowen JM, Verma S, Burrows TD, Loke YW. Recognition of trophoblast HLA class I molecules by decidual NK cell receptors: a review. Placenta 2000;21:81–85.
   PubMed Web of Science ®Google Scholar
• Caniggia I, Winter J, Lye SJ, Post M. Oxygen and placental development during the first trimester: implications for the pathophysiology of pre-eclampsia. Placenta 2000;21:25–30.
   PubMed Web of Science ®Google Scholar
• Rajakumar A, Whitelock KA, Weissfeld LA, Daftary AR, Markovic N, Conrad KP. Selective overexpression of the hypoxia-inducible transcription factor, HIF-2alpha, in placentas from women with preeclampsia. Biol Reprod 2001;64(2):499–506.
   PubMed Web of Science ®Google Scholar
• Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003;111(5):649–658.
   PubMed Web of Science ®Google Scholar
• Tidwell SC, Ho HN, Chiu WH, Torry RJ, Torry DS. Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. American J. Obstetrics Gynecology 2001;184(6):1267–1272.
   PubMed Web of Science ®Google Scholar
• Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350(7): 672–683.
   PubMed Web of Science ®Google Scholar
• Rolfo A, Many A, Racano A, Tal R, Tagliaferro A, Ietta F, Wang J, Post M, Caniggia I. Abnormalities in oxygen sensing define early and late onset preeclampsia as distinct pathologies. PLoS One 2010;12(5):e13288.
   Google Scholar
• Pérez-Sepúlveda A, España-Perrot PP, Fernández XB, Ahumada V, Bustos V, Arraztoa JA, Dobierzewska A, Figueroa-Diesel H, Rice GE, Illanes SE. Levels of key enzymes of methionine-homocysteine metabolism in preeclampsia. Biomed Res Int Epub Aug 2013. doi: 10.1155/2013/731962.
   Google Scholar
• Lee SB, Wong AP, Kanasaki K. Preeclampsia: 2-methoxyestradiol induces cytotrophoblast invasion and vascular development, specifically under hypoxic conditions. Am J Pathol 2010;176:710–720.
   PubMed Web of Science ®Google Scholar
• Kanasaki K, Palmsten K, Sugimoto H, Ahmad S, Hamano Y, Xie L, Parry S, Augustin H, Gattone V, Folkman J, Strauss J, Kalluri R. Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature 2008;453:1117–1121.
   PubMed Web of Science ®Google Scholar
• Pérez-Sepúlveda A, Torres MJ, Valenzuela FJ, Larraín R, Figueroa-Diesel H, Galaz J, Nien JK, Serra R, Michea L, Illanes SE. Low 2-methoxyestradiol levels at the first trimester of pregnancy are associated with the development of pre-eclampsia. Prenatal Diagnosis 2012;32(11):1053–1058.
   PubMed Web of Science ®Google Scholar
• Huppertz B. Placental villous trophoblast: the altered balance between proliferation and apoptosis triggers pre-eclampsia. J für Reproduktions medizin und Endokrinologie 2006;3(2):103–108.
   Google Scholar
• Allaire AD, Ballenger KA, Wells SR, McMahon MJ, Lessey BA. Placental apoptosis in preeclampsia. Obstetrics Gynecology 2000;96(2):271–276.
   PubMed Web of Science ®Google Scholar
• Ishihara N, Matsuo H, Murakoshi H, Laoag-Fernandez JB, Samoto T, Maruo T. Increased apoptosis in the syncytiotrophoblast in human term placentas complicated by either preeclampsia or intrauterine growth retardation. Am J Obstetrics Gynecology 2002;186(1):158–166.
   PubMed Web of Science ®Google Scholar
• Formigli L, Papucci L, Tani A, Schiavone N, Tempestini A, Orlandini GE, Capaccioli S, Orlandini SZ. Aponecrosis: morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis and necrosis, J Cell Physiol 2000;182:41–49.
   Google Scholar
• Wataganara T, Bianchi DW. Fetal cell-free nucleic acids in the maternal circulation: new clinical applications. Ann N Y Acad Sci 2004;1022:90–99.
   PubMed Web of Science ®Google Scholar
• Tjoa ML, Cindrova-Davies T, Spasic-Boskovic O, Bianchi DW, Burton GJ. Trophoblastic oxidative stress and the release of cell-free feto-placental DNA. Am J Pathol 2006;169(2):400–404.
   PubMed Web of Science ®Google Scholar
• Perez-Sepulveda A, Torres MJ, Khoury M, Illanes SE. Innate immune system and preeclampsia. Front Immunol 2014;26(5):244.
   Google Scholar
• Redman CW1, Sargent IL. Immunology of pre-eclampsia. Am J Reprod Immunol 2010;63(6):534–543. doi: 10.1111/j.1600-0897.2010.00831.x. Epub 2010.
   PubMed Web of Science ®Google Scholar
• Hsu P, Santner-Nanan B, Dahlstrom JE, Fadia M, Chandra A, Peek M, Nanan R. Altered decidual DC-SIGN+ Antigen-Presenting cells and impaired regulatory T-cell induction in Preeclampsia. Am. J Pathol 2012;94(6):2149–2160.
   Web of Science ®Google Scholar
• Guiling M, Yanfang L, Zhang J, Liu H. Association between the presence of autoantibodies against adrenoreceptors and severe pre-eclampsia: a pilot study. PLoS One 2013;8(3):e:57983
   Web of Science ®Google Scholar
• Tang Z, Buhimschi IA, Buhimschi CS, Tadesse S, Norwitz E, Niven-Fairchild T, Huang ST, Guller S. Decreased levels of folate receptor-β and reduced numbers of fetal macrophages (Hofbauer cells) in placentas from pregnancies with severe Pre-eclampsia. Am J Reprod Immunol 2013;70(2):104–115.
   PubMed Web of Science ®Google Scholar
• Sacks GP, Studena K, Sargent IL, Redman CWG. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am J Obstetrics Gynecology 1998;179:80–86.
   PubMed Web of Science ®Google Scholar
• Borzychowski AM, Sargent IL, Redman CWG. Inflammation and pre-eclampsia. Semin Fetal Neonatal Med 2006;11(5):309–316.
   PubMed Web of Science ®Google Scholar
• Luppi P, Deloia JA. Monocytes of preeclamptic women spontaneously synthesize proinflammatory cytokines. Clin Immunol 2006;118(2–3):268–275.
   PubMed Web of Science ®Google Scholar
• Cerdeira AS, Rajakumar A, Royle CM, Lo A, Husain Z, Thadhani RI, Sukhatme VP. Conversion of peripheral blood NK Cells to a decidual NK-like phenotype by a cocktail of defined factors. J Immunol 2013;190(8):3938–3948.
   Web of Science ®Google Scholar
• Panda B, Panda A, Uedab I, Abrahams VM, Norwitz ER, Stanice AK, Young BC, Jeffrey E, Eckera L, Altfeld M, Shaw AC, Rueda BR. Dendritic cells in the circulation of women with preeclampsia demonstrate a pro-inflammatory bias secondary to dysregulation of TLR receptors. J Reprod Immunol 2012;94(2):210–215.
   PubMed Web of Science ®Google Scholar
• Fraser R, Whitley G, Johnstone AP, Host AJ, Sebire NJ, Thilaganathan B, Cartwright JE. Impaired decidual natural killer cell regulation of vascular remodelling in early human pregnancies with high uterine artery resistance. J. Pathol 2012;228(3):322–332.
   PubMed Web of Science ®Google Scholar
• Skjaerven R, Vatten LJ, Wilcox AJ, Ronning T, Irgens LM, Lie RT. Recurrence of pre-eclampsia across generations: exploring fetal and maternal genetic components in a population based cohort. Br Med J 2005;331:877.
   PubMed Web of Science ®Google Scholar
• Haig D. Altercation of generations: genetic conflicts of pregnancy. Am J Reprod Immunol 1996;35:226–232.
   PubMed Web of Science ®Google Scholar
• Lie RT, Rasmussen S, Brunborg H, Gjessing HK, Lie-Nielsen E, Irgens LM. Fetal and maternal contributions to risk of pre-eclampsia: population based study. Br Med J 1998;316:1343.
   PubMed Web of Science ®Google Scholar
• Lachmeijer A, Dekker G, Pals G, Aarnoudse J, Kate L, Arngrimsson R. Searching for preeclampsia genes: the current position. Eur J Obstetrics Gynecology Reprod Biol 2002;105(2):94.
   PubMed Web of Science ®Google Scholar
• Trogstad L, Skrondal A, Stoltenberg C, Magnus P, Nesheim BI, Eskild A. Recurrence risk of preeclampsia in twin and singleton pregnancies. Am J Med Genet 2004;126(1):41–45.
   Web of Science ®Google Scholar
• Mütze S, Rudnik-Schöneborn S, Zerres K, Rath W. Genes and the preeclampsia syndrome. J Perinatal Med 2008;36(1):38–58.
   PubMed Web of Science ®Google Scholar
• Valenzuela FJ, Pérez-Sepúlveda A, Torres MJ, Correa P, Repetto GM, Illanes SE. Pathogenesis of preeclampsia: the genetic component. J Pregnancy 2012. doi:10.1155/2012/632732.
   PubMedGoogle Scholar
• Ness R, Roberts J. Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications. Am J Obstetrics Gynecology 1996;175:1365–1370.
   PubMed Web of Science ®Google Scholar
• Dekker G, Sibai B. Primary, secondary, and tertiary prevention of pre-eclampsia. Lancet 2001;357(9251):209–215.
   PubMed Web of Science ®Google Scholar
• Youssef A, Righetti F, Morano D, Rizzo N, Farina A. Uterine artery Doppler and biochemical markers (PAPP-A, PIGF, sFlt-1, P-selectin, NGAL) at 11 + 0 to 13 + 6 weeks in the prediction of late (> 34 weeks) Pre-eclampsia. Prenatal Diagnosis 2011;31(12):1141–1146.
   PubMed Web of Science ®Google Scholar
• Di Lorenzo G, Ceccarello M, Cecotti V, Ronfani L, Monasta L, Vecchi-Brumatti L, et al, First trimester maternal serum PIGF, free β-hCG, PAPP-A, PP-13, uterine artery Doppler and maternal history for the prediction of Preeclampsia. Placenta 2012;33(6):495–501.
   PubMed Web of Science ®Google Scholar
• Poon L, Kametas N, Maiz N, Akolekar R, Nicolaides KH. First-trimester prediction of hypertensive disorders in pregnancy. Hypertension 2009;53:812–818.
   PubMed Web of Science ®Google Scholar
• National Collaborating Centre for Women’s and Children’s Health (UK). Hypertension in Pregnancy: The Management of Hypertensive Disorders During Pregnancy. London: RCOG Press; 2010 ( NICE Clinical Guidelines, No. 107).
   Google Scholar
• Cnossen JS, Morris RK, terRiet G, Mol BW, van der Post JA, Coomarasamy A, Zwinderman AH, Robson SC, Bindels PJ, Kleijnen J, Khan KS. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. CMAJ 2008;178(6):701–711.
   PubMed Web of Science ®Google Scholar
• Velauthar L, Plana MN, Kalidindi M, Zamora J, Thilaganathan B, Illanes SE, Khan KS, Aquilina J. Thangaratinam. Doppler in the first trimester as a risk factor for adverse pregnancy outcomes: a meta-analysis involving 55,974 women. Ultrasound Obstet Gynecol 2014;43(5):500–507.
   PubMed Web of Science ®Google Scholar
• Bhattacharyya SK, Kundu S, Kabiraj SP. Prediction of preeclampsia by midtrimester uterine artery Doppler velocimetry in high-risk and low-risk women. J Obstet Gynaecol India 2012;62(3):297–300.
   PubMedGoogle Scholar
• Parra M, Rodrigo R, Barja P, Bosco C, Fernandez V, Munoz H, Soto-Chacon E. Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction. Am J ObstetGynecol 2005;193(4):1486–1491.
   PubMed Web of Science ®Google Scholar
• Kleinrouweler CE, Wiegerinck MM, Ris-Stalpers C, Bossuyt PM, Van Der Post JA,VonDadelszen P, Mol BW, Pajkrt E. Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis. BJOG 2012;119(7):778–787.
   PubMed Web of Science ®Google Scholar
• Spencer K, Yu CK, Savvidou M, Papageorghiou AT, Nicolaides KH. Prediction of preeclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22 + 0 to 24 + 6 weeks’ gestation. Ultrasound Obstet Gynecol 2006;27(6): 658–6310.
   PubMed Web of Science ®Google Scholar
• Romero R, Kusanovic JP, Than NG, Erez O, Gotsch F, Espinoza J, et al. First- trimester maternal serum PP13 in the risk assessment for preeclampsia. Am J Obstet Gynecol 2008;199:122.
   PubMed Web of Science ®Google Scholar
• Than NG, Pick E, Bellyei S, Szigeti A, Burger O, Berente Z, et al. Functional analyses of placental protein 13/galectin-13. Eur J Biochem 2004;271:2.
   Google Scholar
• Odibo AO, Zhong Y, Goetzinger KR, Odibo L, Bick JL, Bower CR, et al. First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia. Placenta. 2011;32(8):598–602.
   PubMed Web of Science ®Google Scholar
• Akolekar R, Syngelaki A, Beta J, Kocylowski R, Nicolaides KH. Maternal serum placental protein 13 at 11–13 weeks of gestation in preeclampsia. Prenat Diagn 2009;29(12):1103–1108.
   PubMed Web of Science ®Google Scholar
• Wortelboer EJ, Koster MP, Cuckle HS, Stoutenbeek PH, Schielen PC, Visser GH. First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia. BJOG 2010;1171384–1389.
   Google Scholar
• Poon LC, Akolekar R, Lachmann R, Beta, Nicolaides KH. Hypertensive disorders in pregnancy: screening by biophysical and biochemical markers at 11–13 weeks. Ultrasound Obstet Gynecol 2010;35(6):662–670.
   PubMed Web of Science ®Google Scholar
• Giguere Y, Charland M, Bujold E, Bernard N, Grenier S, Rousseau F. Combining biochemical and ultrasonographic markers in predicting preeclampsia: a systematic review. Clin Chem 2010;56(3):361–375.
   PubMed Web of Science ®Google Scholar
• Fayyad AM, Harrington KF. Prediction and prevention of preeclampsia and IUGR. Early Hum Dev 2005;81(11):865–876.
   PubMed Web of Science ®Google Scholar
• Tjoa ML, Cindrova-Davies T, Spasic-Boskovic O, Bianchi DW, Burton GJ. Trophoblastic oxidative stress and the release of cell-free feto-placental DNA. Am J Pathol 2006;169(2):400–404.
   PubMed Web of Science ®Google Scholar
• Cotter AM, Martin CM, O’leary JJ, Daly SF. Increased fetal DNA in the maternal circulation in early pregnancy is associated with an increased risk of preeclampsia. Am J Obstet Gynecol 2004;191(2):515–520.
   PubMed Web of Science ®Google Scholar
• Leung DN, Smith SC, To KF, Sahota DS, Baker PN. Increased placental apoptosis in pregnancies complicated by preeclampsia. Am J Obstet Gynecol 2001;184(6):1249–1250.
   PubMed Web of Science ®Google Scholar
• Lo YM, Leung TN, Tein MS, Sargent IL, Zhang J, Lau TK, Haines CJ, Redman CW. Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. ClinChem 1999;45(2):184–188.
   Google Scholar
• Zhong XY, Laivuori H, Livingston JC, Ylikorkala O, Sibai BM, Holzgreve W, et al. Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia. Am J Obstet Gynecol 2001;84(3):414–419.
   Web of Science ®Google Scholar
• Illanes S, Parra M, Serra R, Pino K, Figueroa-Diesel H, Romero C, et al. Increased free fetal DNA levels in early pregnancy plasma of women who subsequently develop preeclampsia and intrauterine growth restriction. Prenat Diagn 2009;29(12):1118–1122.
   PubMed Web of Science ®Google Scholar
• Sifakis S, Zaravinos A, Maiz N, Spandidos DA, Nicolaides KH. First-trimester maternal plasma cell-free fetal DNA and preeclampsia. Am J Obstet Gynecol 2009;201(5):472.e1–e7.
   PubMed Web of Science ®Google Scholar
• Yu H, Shen Y, Ge Q, He Y, Qiao D, Ren M, Zhang J. Quantification of maternal serum Cell-Free Fetal DNA in early-onset preeclampsia. Int J Mol Sci 2013;14:7571–7582.
   PubMed Web of Science ®Google Scholar
• Yu CK, Smith GC, Papageorghiou AT, Cacho AM, Nicolaides KHF. et al .Medicine Foundation Second Trimester Screening Group. An integrated model for the prediction of preeclampsia using maternal factors and uterine artery Doppler velocimetry in unselected low-risk women. Am J Obstet Gynecol. 2005;193(2):429–3611.
   Google Scholar
• Poon LC, Maiz N, Valencia C, Plasencia W, Nicolaides KH. First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia. Ultrasound Obstet Gynecol 2009;33(1):23–33.
   PubMed Web of Science ®Google Scholar
• Parra M, Rodrigo R, Barja P, Bosco C, Fernandez V, Munoz H, Soto-Chacon E. Screening test for preeclampsia through assessment of uteroplacental blood flow and biochemical markers of oxidative stress and endothelial dysfunction. Am J ObstetGynecol 2005;193(4):1486–1491.
   PubMed Web of Science ®Google Scholar
• Akolekar R, Syngelaki A, Sarquis R, Zvanca M, Nicolaides KH. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks. PrenatDiagn 2011;31:66–74.
   Google Scholar
• Caradeux J, Serra R, Nien J-K, Pérez-Sepulveda A, Schepeler M, Guerra F, et al. First trimester prediction of early onset preeclampsia using demographic, clinical, and sonographic data: a cohort study. PrenatDiagn 2013;33(8):732–736.
   Google Scholar
• Oliveira N, Magder LS, Blitzer MG, Baschat A. First-trimester prediction of pre-eclampsia: external validity of algorithms in a prospectively enrolled cohort. Ultrasound Obstet Gynecol 2014;44:279–285.
   PubMed Web of Science ®Google Scholar
• Kenny L, Black M, Poston L, Taylor R. Early Pregnancy prediction of preeclampsia in nulliparous women, combining clinical risk and biomarkers, The Screening for Pregnancy Endpoints (SCOPE) International Cohort Study. Hypertension 2014;64:644–652.
   PubMed Web of Science ®Google Scholar
• Crovetto F, Figueras F, Triunfo S, Crispi F. First trimester screening for early and late preeclampsia based on maternal characteristics, biophysical parameters and angiogenic factors. Prenat Diagnos 2015;35(2):183–191.
   PubMed Web of Science ®Google Scholar
• Waljee A, Higgins P, Singal A. A primer on Predictive Models. Clinical and Translational Gastroenterology 2014;2:5:e44
   Google Scholar
• Rumbold A, Duley L, Crowther CA, Haslam R. Antioxidants for preventing pre-eclampsia. Cochrane Review 2008;Jan 23;(1):CD004227.
   Google Scholar
• Chappell LC, Seed PT, Briley AL, Kelly FJ, Lee R, Hunt BJ, et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomized trial. Lancet 1999;354(9181):810–816.
   PubMed Web of Science ®Google Scholar
• Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): Lancet 2006;367(9517):1145–1154.
   PubMed Web of Science ®Google Scholar
• Conde-Agudelo A, Romero R, Kusanovic JP, Hassan SS. Supplementation with vitamins C and E during pregnancy for the prevention of preeclampsia and other adverse maternal and perinatal outcomes: a systematic review and metaanalysis. 2011;204(6):503.e1–12.
   Google Scholar
• Salles AMR, Galvao TF, Silva MT, Motta LCD, Pereira MG. Antioxidants for preventing preeclampsia: a systematic review. Sci World J 2012; 2012:243476 doi: 10.1100/2012/243476. Epub 2012 Apr 19.
   Web of Science ®Google Scholar
• Parrish MR, Martin JN Jr, Lamarca BB, Ellis B, Parrish SA, Owens MY, et al. Randomized, placebo controlled, double blind trial evaluating early pregnancy phytonutrient supplementation in the prevention of preeclampsia. J Perinatol Off J Calif Perinat Assoc 2013;33(8):593–599.
   PubMed Web of Science ®Google Scholar
• Duley L, Henderson-Smart DJ, Meher S, King JF. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2007;Apr 18;(2):CD004659.
   Google Scholar
• Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, Forest JC, Giguère Y. Prevention of preeclampsia and intra uterine growth restriction with aspirin started in early pregnancy: a meta-analysis. ObstetGynecol 2010;116:402–414.
   Web of Science ®Google Scholar
• Roberge S, Nicolaides KH, Demers S, Villa P, Bujold E. Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis. Ultrasound Obstet Gynecol 2013;41(5):491–499.
   PubMed Web of Science ®Google Scholar
• Smeeth L, Williams D. Can a dietary supplement prevent pre-eclampsia? BMJ 2011;19:342:d2777.
   Google Scholar
• Holden DP, Fickling SA, Whitley GSTJ, Nussey SS. Plasma concentrations of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and pre-eclampsia. Am J Obs Gynae 1998;178:551–556.
   PubMed Web of Science ®Google Scholar
• Vadillo-Ortega F, Perichart-Perera O, Espino S, Avila-Vergara MA, Ibarra I, Ahued R, Godines M, Parry S, Macones G, Strauss JF. Effect of supplementation during pregnancy with l-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: randomized controlled trial. BMJ 2011;19,342:d2901.
   Google Scholar
• Belizan JM, Villar J, Zalazar A, Rojas L, Chan D, Bryce GF. Preliminary evidence of the effect of calcium supplementation on blood pressure in normal pregnant women. Am J Obstetrics Gynecology 1983;146:175–180.
   PubMed Web of Science ®Google Scholar
• Villar J, Abdel-Aleem H, Merialdi M, Mathai M, Ali MM, Zavaleta N, et al. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. Am J Obstet Gynecol.2006; 194(3):639–649.
   PubMed Web of Science ®Google Scholar
• Hofmeyr GJ, Lawrie TA, Atallah AN, Duley L, Torloni MR. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 2014;6:CD001059.
   Google Scholar
• Hyppönen E, Cavadino A, Williams D, Fraser A, Vereczkey A, Fraser WD, Bánhidy F, Lawlor D, Czeizel AE. Vitamin D and pre-eclampsia: original data, systematic review and meta-analysis. Ann Nutr Metab 2013;63(4):331–340. doi: 10.1159/000358338. Epub 2014 Feb 28.
   PubMed Web of Science ®Google Scholar
• Allen R, Rogozinska E, Sivarajasingam P, Khan KS, Thangaratinam S Effect of diet- and lifestyle-based metabolic risk-modifying interventions on preeclampsia: a meta-analysis. Acta Obstet Gynecol Scand. 2014;93(10):973–985.
   PubMed Web of Science ®Google Scholar
• Saccone G, Berghella V. Omega-3 long chain polyunsaturated fatty acids to prevent preterm birth: a systematic review and meta-analysis. Obstet Gynecol 2015;125(3):663–672.
   PubMed Web of Science ®Google Scholar
• Mogollon JA, Boivin C, Philippe K, Turcotte S, Lemieux S, Blanchet C, Bujold E, Dodin S. Consumption of chocolate in pregnant women and risk of preeclampsia: a systematic review. Syst Rev 2013;2:114. doi: 10.1186/2046-4053-2-114.
   PubMedGoogle Scholar